Search
for

    Sort by

    Research 181–210 of 1000+

    1. Hair Follicle Reconstruction and Stem Cells InTech eBooks · 2017 · 2 citations
    2. Alopecia Areata InTech eBooks · 2017 · 1 citations
    3. New drugs under investigation for the treatment of alopecias Expert Opinion on Investigational Drugs · 2019 · 26 citations
    4. Treatment of severe alopecia areata with baricitinib JAAD Case Reports · 2019 · 25 citations
    5. An excellent response to tofacitinib in a Brazilian adolescent patient with alopecia areata: A case report and a review of the literature Clinical Case Reports · 2019 · 11 citations
    6. Suspected upadacitinib-associated drug hypersensitivity mimicking disease exacerbation in ulcerative colitis Clinical Journal of Gastroenterology · 2026
    7. Editorial: Exploring innovative therapies for rare inflammatory skin diseases Frontiers in Medicine · 2026
    8. JAK-Inhibitors Beyond the Label: Emerging Applications in Dermatology Medicina · 2026
    9. Alopecia areata: from immunopathogenesis to emerging therapeutic approaches Frontiers in Immunology · 2025
    10. Evaluating Current and Emergent JAK Inhibitors for Alopecia Areata: A Narrative Review Dermatology and Therapy · 2025
    11. The Changing Landscape of Alopecia Areata: The Therapeutic Paradigm Advances in Therapy · 2017 · 77 citations
    12. Treatment of an alopecia areata patient with tofacitinib results in regrowth of hair and changes in serum and skin biomarkers Experimental Dermatology · 2016 · 70 citations
    13. Experience with oral tofacitinib in 8 adolescent patients with alopecia universalis Journal of the American Academy of Dermatology · 2017 · 49 citations
    14. Successful Treatment of Refractory Alopecia Areata Universalis and Psoriatic Arthritis, But Not of Plaque Psoriasis with Tofacitinib in a Young Woman Acta dermato-venereologica · 2016 · 24 citations
    15. Frontal fibrosing alopecia: a disease fascinating for the researcher, disappointing for the clinician and distressing for the patient Experimental Dermatology · 2016 · 6 citations
    16. Integrated single-cell chromatin and transcriptomic analyses of peripheral immune cells in patients with alopecia areata Frontiers in Immunology · 2025 · 4 citations
    17. Improvement of Psoriasis, Psoriatic Arthritis, and Alopecia Universalis during Treatment with Tofacitinib: A Case Report Case Reports in Dermatology · 2020 · 3 citations
    18. Adverse events in patients treated with Jak‐inhibitors for alopecia areata: A systematic review 2023 · 2 citations
    19. Alopecia areata Journal of the American Academy of Dermatology · 2018 · 2 citations
    20. Baricitinib for Alopecia Universalis Following Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms Eurasian Journal of Medicine · 2026
    21. “<i>Nomen Omen</i>: The Myth of God Janus” JEADV Clinical Practice · 2025
    22. Dermatologic Comorbidities Associated with Atopic Dermatitis Towards a Shared Therapeutical Approach: A Narrative Review Dermatology and Therapy · 2025
    23. Modern Management Approaches for Alopecia Areata Вопросы современной педиатрии · 2025
    24. Analyzing the role of tofacitinib in treatment of alopecia areata: A retrospective analysis from a tertiary care center of North India National Journal of Physiology, Pharmacy and Pharmacology · 2023
    25. Psychophysiological Mechanisms of Stress Impact on Hair Loss Processes International Journal of Science and Research (IJSR) · 2025
    26. Treatment of alopecia areata with JAK inhibitors DiRROS repository (University of Maribor) · 2025
    27. 1313 Fzd2 controls multiple aspects of epidermal development through distinct signaling mechanisms Journal of Investigative Dermatology · 2018 · 1 citations
    28. Current Trends and Emerging Paradigms in the Treatment of Alopecia Areata Quality in Sport · 2026
    29. INIBIDORES DA JANUS QUINASE PARA O TRATAMENTO DA ALOPECIA AREATA Revista Foco · 2025
    30. Nouvelles thérapeutiques dans la prise en charge de l’alopécie androgénétique HAL (Le Centre pour la Communication Scientifique Directe) · 2025